SEC Form D · Amendment · filed January 22, 2024
SIRPant Immunotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Robert C. Towarnicki · Hummelstown, PAExec · DirectorRifat C. Pamukcu · Hummelstown, PADirectorTim C. Van Treuren · Hummelstown, PADirectorJohn Fucci · Hummelstown, PADirectorThomas J. Nedeau · New York, NYExec · DirectorTim C. Van Treuren · Hummelstown, PADirectorDinyar G. Mistry · Nashville, TNDirectorMishthi G. Hanson · Nashville, TNDirectorRoger Sawhney · Germantown, MDDirectorJeffrey Wakeman · Cornelius, NCDirectorVanessa A. Anton · Fairlawn, OHDirectorJohn S. Nebesky · Fairlawn, OHExec · DirectorAli Motamed · Boston, MADirectorRoger Sawhney · Gaithersburg, MDDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗